Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI

NCT03173287 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2017-06-01

No results posted yet for this study

Summary

Quantification of hepatic fibrosis by IVIM sequences in 1.5T MRI.

Conditions

  • Liver Fibrosis
  • MRI
  • IVIM
  • Liver Biopsy

Interventions

PROCEDURE

Quantification of liver fibrosis

Procedure MRI and liver biopsy

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Benoit MAGNIN · CHU de Clermont-Ferrand

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2017-03-01
Completion
2018-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03173287 on ClinicalTrials.gov